Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017

King, Lauren A.; Michels, Kara A.; Graubard, Barry I.; Trabert, Britton

doi:10.1007/s10552-021-01410-8

Cited by 22 publications

(15 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the present study showed that gravidity affects OC use. Similar to the results of this study, a study analyzing US National Health and Nutrition Examination Survey (NHANES) data [ 29 ] identified differences in trends of OC use according to pregnancy history, suggesting that the use of OC to avoid unintended pregnancies may increase with higher gravidity.…”

Section: Discussionsupporting

confidence: 81%

Trends and Factors Associated with Oral Contraceptive Use among Korean Women

Park

Kim

2021

Healthcare

View full text Add to dashboard Cite

Although oral contraceptives (OC) are widely used, few national-level epidemiologic studies have evaluated the prevalence of OC use and factors related to their use in Korea. We performed a population-based cross-sectional study on OC use by premenopausal women aged 20–59 years residing in Korea. We used secondary data from the 2010–2019 National Health and Nutrition Examination Survey to examine trends in the annual prevalence of OC use between 2010 and 2019, and factors influencing OC use. Based on data from 14,386 premenopausal women, the average annual prevalence of OC use was 8.2–10.7% between 2010 and 2014; it increased to 12.6–14.4% during 2015–2019. The prevalence of OC use was significantly higher in women with higher (≥5) than lower gravidity (<5). In addition, among sociodemographic factors, education level, household income, cigarette smoking, and alcohol drinking were significantly associated with OC use in Korean women. As OC use is affected by sociodemographic factors, a contraceptive plan that considers sociodemographic factors is needed to establish an effective family planning policy.

show abstract

Section: Discussionsupporting

confidence: 81%

Trends and Factors Associated with Oral Contraceptive Use among Korean Women

Park

Kim

2021

Healthcare

View full text Add to dashboard Cite

show abstract

“…The use of long acting reversible contraception (LARC), especially the intrauterine devices (IUDs) has dramatically increased over the last thirty years. Globally, IUDs are one of the preferred form of contraception, with almost 20% of women worldwide using an IUD as their contraception of choice [ 1 ].…”

Section: Introductionmentioning

confidence: 99%

In-office hysteroscopic removal of retained or fragmented intrauterine device without anesthesia: a cross-sectional analysis of an international survey

et al. 2022

View full text Add to dashboard Cite

To investigate about the opinions of gynecologists regarding the in-office hysteroscopic removal of retained or fragmented intrauterine device (IUD) without anesthesia. An online survey was made available to gynecologists who routinely performed in-office hysteroscopy. Five areas of interest were analyzed: average number of hysteroscopic procedures performed without anesthesia, availability on their local market of the different types of hormonal and non-hormonal IUDs, reasons for the hysteroscopic removal of the IUD, types of IUDs that were more commonly found retained or fragmented and, overall difficulty of the hysteroscopic removal. A total of 419 surgeons voluntarily responded the survey, of which 19 were excluded for not performing in-office hysteroscopy. The most commonly available IUD was the Levonorgestrel-based Mirena (Bayer Healthcare, Germany) or similar, (399/400, 99.7%), followed by Copper T (Paragard, CooperSurgical INC, United States) (397/400, 99.2%), Multiload (234/400, 58.5%) and Jaydess (Bayer Healthcare, Germany) (227/400, 56.7%). The intracavitary retention of the IUD with (44.5%, 178/400) and without (42.2%, 169/400) visible strings accounted as the most common reason for undergoing hysteroscopic IUD removal. Copper T IUD was the most common intracavitary retained (297/400, 74.2%) as well as fragmented device (236/400, 59.9%). The in-office hysteroscopic removal of the IUD was considered an easy procedure by almost all the operators (386/400, 96.5%). In-office hysteroscopy without anesthesia is seen as a feasible and easy approach to remove retained or fragmented IUDs inside the uterine cavity or cervical canal. While the Levonorgestrel-based IUD is the most commercialized, Copper T IUDs are the most commonly found retained or fragmented.

show abstract

“…In 2019, IUDs and oral contraceptive pills were among the most popular methods of reversible contraception globally, adopted by 17 and 16% of reproductive-aged contraceptive users, respectively [ 39 ]. From 2008 to 2014, the prevalence of IUDs and implants rose at a rate of 8.3% annually in the United States, corresponding to a decline in the use of oral contraceptive pills [ 40 , 41 ]. Similar trends have been reported in Europe, where use of LARC methods increased successively between 2010 to 2013, accounting for up to 20% of contraceptive use in Sweden and 18% of that in Finland [ 42 ].…”

Section: Introductionmentioning

confidence: 99%

Beyond the pill: contraception and the prevention of hereditary ovarian cancer

Xia

Kotsopoulos

2022

Hered Cancer Clin Pract

View full text Add to dashboard Cite

BRCA1 and BRCA2 mutation carriers face an elevated lifetime risk of developing ovarian cancer. Oral contraceptives have been shown to significantly decrease the risk of ovarian cancer by approximately 50% in this high-risk population. Changes in contraceptive formulations and patterns of use over time have introduced lower hormonal dosages, different steroid types and non-oral routes of administration. Specifically, there has been a considerable shift in patterns of contraceptive use and the increase in the uptake of non-oral, long-acting, reversible contraception (e.g., intrauterine devices, implants, injections) has corresponded to a decline in oral contraceptive pill use. Whether or not these other methods confer a protective effect against ovarian cancer in the general population is not clear. To our knowledge, there have been no such studies conducted among BRCA mutation carriers. Furthermore, the impact of these changes on the risk of developing ovarian cancer is not known. In this article, we will review the existing epidemiologic evidence regarding the role of contraceptives and the risk of ovarian cancer with a focus on women with a BRCA1 or BRCA2 mutation. We will discuss recent findings and gaps in the knowledge while extrapolating from studies conducted among women from the noncarrier population.

show abstract

Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017

Cited by 22 publications

References 26 publications

Trends and Factors Associated with Oral Contraceptive Use among Korean Women

Trends and Factors Associated with Oral Contraceptive Use among Korean Women

In-office hysteroscopic removal of retained or fragmented intrauterine device without anesthesia: a cross-sectional analysis of an international survey

Beyond the pill: contraception and the prevention of hereditary ovarian cancer

Contact Info

Product

Resources

About